![](https://www.rickilewis.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeVBUQVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4190d5c8d5e34d1ea223c728cbb809e33a0d1a24/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJYW5CbkJqb0dSVlE2RkhKbGMybDZaVjkwYjE5c2FXMXBkRnNIYVFMZ0FXa0M0QUU9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--d00c0b801be2eac628730b2b4ffb891cbdd69dfe/269412-web.jpg)
As the early weeks of the pandemic unfolded and health care workers struggled to save so many lives, researchers began tracking the path of destruction of SARS-CoV-2, focusing at first on the tango between cells of the lung and of the immune system.
Just as mRNA vaccine technology was years in the making, so was a powerful way to illuminate cellular pathology: single-cell transcriptomics using single-cell RNA-Seq, aka simply RNA-Seq. It detects the abundance of all unique messenger RNA (mRNA) molecules in a cell, collectively called the transcriptome. RNA-Seq reveals the suite of proteins a cell produces in response to a stimulus – such as an influx of viruses. The technology is more than a decade old.
But cataloging the abundance of mRNAs in a lung cell, or in any cell, isn't meaningful without the context of the organ of which it is a part. It's a little like counting the number of times the words "the," "a," and "there" appear in a novel and trying to deduce the narrative.
To continue reading, go to DNA Science, where this post first appeared.